Showing results (201-210 of 1,085) with videos related to
Sort By:
Pageof 109
The American Journal of Cardiology|October 24, 2006
Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery diseaseEsther Bernardo, Dominick J Angiolillo, Celia Ramírez, et al.Thrombosis and Haemostasis|October 21, 2011
Platelet function profiles in the elderly: results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivityPiera Capranzano, Claudia Tamburino, Davide Capodanno, et al.International Journal of Cardiology|March 12, 2026
Real-world adoption of the 2023 European Society of Cardiology guidelines regarding antiplatelet strategies in acute coronary syndromes: Insights from the European READAPT-2 surveyDominick J Angiolillo, David Erlinge, Chris P Gale, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 7, 2015
Platelet inhibition with ticagrelor versus clopidogrel in Hispanic patients with stable coronary artery disease with or without diabetes mellitusLeonardo C Clavijo, Juan Maya, Glenn Carlson, et al.Lancet (London, England)|April 18, 2021
Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysisMattia Galli, Stefano Benenati, Davide Capodanno, et al.Journal of Clinical Medicine|August 14, 2025
Antiplatelet Monotherapies for Long-Term Secondary Prevention Following Percutaneous Coronary InterventionClaudio Laudani, Daniele Giacoppo, Antonio Greco, et al.Journal of the American Heart Association|December 8, 2020
Lipid Management in Patients Presenting With Acute Coronary Syndromes: A ReviewBimmer E Claessen, Paul Guedeney, C Michael Gibson, et al.Journal of Thrombosis and Thrombolysis|February 22, 2020
Bioavailability of aspirin in fasted and fed states of a novel pharmaceutical lipid aspirin complex formulationDominick J Angiolillo, Deepak L Bhatt, Frank Lanza, et al.Mayo Clinic Proceedings|February 5, 2025
Relevance of High Bleeding Risk and Postdischarge Bleeding in Patients Undergoing Percutaneous Coronary InterventionBrenden S Ingraham, Marco Valgimigli, Dominick J Angiolillo, et al.JACC. Cardiovascular Interventions|February 23, 2013
High-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) studyMario Leoncini, Anna Toso, Mauro Maioli, et al.Pageof 109